Performance of Artificial Intelligence in Skin Cancer Detection: An Umbrella Review of Systematic Reviews and Meta‐Analyses
Leistung künstlicher Intelligenz bei der Hautkrebsdetektion: Umbrella Review systematischer Übersichten und Metaanalysen
International Journal of Dermatology · 2026-01 · 65 (1) · 69-85
DOI: 10.1111/ijd.17981 ↗Auf einen Blick
Das Umbrella Review zeigt: KI-Modelle erzielten hohe diagnostische Genauigkeit bei der Hautkrebsdetektion. Besonders CNN und SVM schnitten gut ab; KI-gestützte Ansätze verbesserten die Genauigkeit bei allen Klinikergruppen.
Fragestellung
Wie gut ist die diagnostische Leistung von KI-Modellen bei der Erkennung von Hautkrebs?
Methode
Umbrella Review von Metaanalysen; Suche in PubMed, Web of Science und Embase bis 28. Januar 2025.
Ergebnisse
11 Metaanalysen mit 551 Studien. CNN und SVM zeigten die höchste diagnostische Leistung; SVM für Melanom vs. melanozytäre Läsionen mit Sensitivität 91 % und Spezifität 94 %.
Schlussfolgerung der Autor:innen
Die Autor:innen folgern, dass die Integration KI-gestützter Werkzeuge in klinische Abläufe, besonders in der Primärversorgung, die diagnostische Genauigkeit verbessern und verpasste Fälle reduzieren kann.
Kernaussagen
- 11 Metaanalysen mit 551 Studien
- SVM: Sensitivität 91 % und Spezifität 94 % bei Melanom vs. melanozytären Läsionen
- KI-gestützte Ansätze verbesserten die diagnostische Genauigkeit bei allen Klinikergruppen
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Dermatology, online erschienen am 31.07.2025. Verfasst von Sahand Karimzadhagh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Skin Neoplasms, Artificial Intelligence, Melanoma, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 66 Literaturangaben.
Abstract (Originalsprache)
Skin cancer has one of the highest incidence rates among malignancies. A shortage of clinical expertise, particularly in primary care, contrasts with the promising performance of artificial intelligence (AI) models in assisting clinicians. However, a comprehensive evaluation of AI‐based diagnostic accuracy across various skin cancers is essential before integration into routine clinical practice. This umbrella review synthesizes evidence from meta‐analyses assessing AI model performance in skin cancer detection. We searched PubMed, Web of Science, and Embase for relevant meta‐analyses published until January 28, 2025. We included 11 meta‐analyses comprising 551 studies from various skin cancer types, clinical settings, and diagnostic modalities. Convolutional neural networks (CNN) and support vector machines (SVM) demonstrated the highest diagnostic performance, with CNN achieving the highest overall accuracy. AI models distinguishing melanoma from melanocytic lesions outperformed those detecting melanoma across all skin cancers, with SVM achieving the highest sensitivity (91%) and specificity (94%). For squamous cell carcinoma, machine learning models trained on hyperspectral imaging demonstrated the highest sensitivity (90.1%) and specificity (92.65%). In differentiating benign from malignant lesions, models exhibited a sensitivity of 87% and a specificity of 86.4%. AI‐assisted approaches significantly improved diagnostic accuracy among all clinicians, with generalists and nurse practitioners benefiting more than experienced dermatologists. Deep learning models in primary care, trained on smartphone images, achieved higher sensitivity (90%) and specificity (85%) than general practitioners. AI models significantly outperformed junior dermatologists and nonspecialists compared to senior dermatologists. Hence, integrating AI‐assisted tools into clinical workflows, particularly in primary settings, can enhance diagnostic accuracy and minimize missed cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Clinical Research Development Unit of Ghaem Hospital, Guilan University of Medical Sciences, Rasht, Iran.
- Student Research Committee, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
- Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut, USA.
- Neuroscience Research Center, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
ORCID-Profile: Sahand Karimzadhagh, Shahriar Ghodous, Reza M Robati, Elahe Abbaspour, Mohamad Goldust, Nooshin Zaresharifi, Shirin Zaresharifi
Zitieren
APA
Karimzadhagh, S., Ghodous, S., Robati, R. M., Abbaspour, E., Goldust, M., Zaresharifi, N., & Zaresharifi, S. (2026). Performance of Artificial Intelligence in Skin Cancer Detection: An Umbrella Review of Systematic Reviews and Meta‐Analyses. International Journal of Dermatology, 65(1), 69-85. https://doi.org/10.1111/ijd.17981
Vancouver
Karimzadhagh S, Ghodous S, Robati RM, Abbaspour E, Goldust M, Zaresharifi N, et al. Performance of Artificial Intelligence in Skin Cancer Detection: An Umbrella Review of Systematic Reviews and Meta‐Analyses. International Journal of Dermatology. 2026;65(1):69-85. doi:10.1111/ijd.17981
BibTeX
@article{Karimzadhagh2026,
author = {Karimzadhagh, Sahand and Ghodous, Shahriar and Robati, Reza M and Abbaspour, Elahe and Goldust, Mohamad and Zaresharifi, Nooshin and Zaresharifi, Shirin},
title = {Performance of Artificial Intelligence in Skin Cancer Detection: An Umbrella Review of Systematic Reviews and Meta‐Analyses},
journal = {International Journal of Dermatology},
year = {2026},
volume = {65},
number = {1},
pages = {69--85},
doi = {10.1111/ijd.17981}
}
EUVIMED